miR-130a-Mediated KLF3 Can Inhibit the Growth of Lung Cancer Cells

References

• Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol. 2016;893:1–19. doi:10.1007/978-3-319-24223-1_126667336
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Chen WQ, Zuo TT, Zheng RS, Zeng HM, Zhang SW, He J. [Lung cancer incidence and mortality in China in 2013]. Chin J Oncol. 2017;39(10):795–800. doi:10.3760/cma.j.issn.0253-3766.2017.10.015.Chinese.
   Google Scholar
• Yu T, Zhong D. [Clinical development of immunotherapy for small cell lung cancer]. Chin J Lung Cancer. 2018;21(12):918–923. doi:10.3779/j.issn.1009-3419.2018.12.10.Chinese.
   Google Scholar
• Nanavaty P, Alvarez MS, Alberts WM. Lung cancer screening: advantages, controversies, and applications. Cancer Control. 2014;21(1):9–14. doi:10.1177/10732748140210010224357736
   PubMed Web of Science ®Google Scholar
• Yan X, Jiao SC, Zhang GQ, Guan Y, Wang JL. Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer. Cancer Gene Ther. 2017;24(2):57–63. doi:10.1038/cgt.2016.4028084319
   PubMed Web of Science ®Google Scholar
• Usuda K, Sagawa M, Motomo N, et al. Recurrence and metastasis of lung cancer demonstrate decreased diffusion on diffusion-weighted magnetic resonance imaging. Asian Pac J Cancer Prev. 2014;15(16):6843–6848. doi:10.7314/apjcp.2014.15.16.684325169535
   PubMedGoogle Scholar
• Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol. 2007;23(1):175–205. doi:10.1146/annurev.cellbio.23.090506.12340617506695
   PubMed Web of Science ®Google Scholar
• Ritchie W. microRNA target prediction. Methods Mol Biol. 2017;1513:193–200. doi:10.1007/978-1-4939-6539-7_1327807838
   PubMedGoogle Scholar
• Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202–1207. doi:10.1016/j.jaci.2017.08.03429074454
   PubMed Web of Science ®Google Scholar
• Liu Y, Li Y, Wang R, et al. MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells. J Exp Clin Cancer Res. 2016;35(1):19. doi:10.1186/s13046-016-0296-026817584
   PubMed Web of Science ®Google Scholar
• Kong X, Zhang J, Li J, Shao J, Fang L. MiR-130a-3p inhibits migration and invasion by regulating RAB5B in human breast cancer stem cell-like cells. Biochem Biophys Res Commun. 2018;501(2):486–493. doi:10.1016/j.bbrc.2018.05.01829746865
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang X, Tang W, et al. miR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-kappaB in high-grade serous ovarian carcinoma. Cell Death Differ. 2017;24(12):2089–2100. doi:10.1038/cdd.2017.12928800130
   PubMed Web of Science ®Google Scholar
• Yang H, Zhang H, Ge S, et al. Exosome-derived miR-130a activates angiogenesis in gastric cancer by targeting C-MYB in vascular endothelial cells. Mol Ther. 2018;26(10):2466–2475. doi:10.1016/j.ymthe.2018.07.02330120059
   PubMed Web of Science ®Google Scholar
• Zheng Y, Xiang L, Chen M, Xiang C. MicroRNA130a inhibits the proliferation, migration and invasive ability of hepatocellular carcinoma cells by downregulating rho-kinase 2. Mol Med Rep. 2018;18(3):3077–3084. doi:10.3892/mmr.2018.928330015839
   PubMed Web of Science ®Google Scholar
• Koul R, Rathod S, Dubey A, Bashir B, Chowdhury A. Comparison of 7th and 8th editions of the UICC/AJCC TNM staging for non-small cell lung cancer in a non-metastatic North American cohort undergoing primary radiation treatment. Lung Cancer. 2018;123:116–120. doi:10.1016/j.lungcan.2018.06.02930089581
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods (San Diego, Calif). 2001;25(4):402–408. doi:10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Verma V, Lautenschlaeger T. MicroRNAs in non-small cell lung cancer invasion and metastasis: from the perspective of the radiation oncologist. Expert Rev Anticancer Ther. 2016;16(7):767–774. doi:10.1080/14737140.2016.119195027215143
   PubMed Web of Science ®Google Scholar
• Lemjabbar-Alaoui H, Hassan OU, Yang YW, Buchanan P. Lung cancer: biology and treatment options. Biochim Biophys Acta. 2015;1856(2):189–210. doi:10.1016/j.bbcan.2015.08.00226297204
   PubMed Web of Science ®Google Scholar
• Watanabe SI, Nakagawa K, Suzuki K, et al. Neoadjuvant and adjuvant therapy for stage III non-small cell lung cancer. Jpn J Clin Oncol. 2017;47(12):1112–1118. doi:10.1093/jjco/hyx14729136212
   PubMed Web of Science ®Google Scholar
• Li WF, Dai H, Ou Q, Zuo GQ, Liu CA. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway. Tumour Biol. 2016;37(5):5885–5895. doi:10.1007/s13277-015-4456-126589417
   PubMedGoogle Scholar
• Hollis M, Nair K, Vyas A, Chaturvedi LS, Gambhir S, Vyas D. MicroRNAs potential utility in colon cancer: early detection, prognosis, and chemosensitivity. World J Gastroenterol. 2015;21(27):8284–8292. doi:10.3748/wjg.v21.i27.828426217080
   PubMed Web of Science ®Google Scholar
• Yu XF, Wang J, Ou N, et al. The role of miR-130a-3p and SPOCK1 in tobacco exposed bronchial epithelial BEAS-2B transformed cells: comparison to A549 and H1299 lung cancer cell lines. J Toxicol Environ Health A. 2019;82(15):862–869. doi:10.1080/15287394.2019.166447931526129
   PubMed Web of Science ®Google Scholar
• Lin L, Lin H, Wang L, Wang B, Hao X, Shi Y. miR-130a regulates macrophage polarization and is associated with non-small cell lung cancer. Oncol Rep. 2015;34(6):3088–3096. doi:10.3892/or.2015.430126398698
   PubMed Web of Science ®Google Scholar
• Liu B, Qu J, Xu F, et al. MiR-195 suppresses non-small cell lung cancer by targeting CHEK1. Oncotarget. 2015;6(11):9445–9456. doi:10.18632/oncotarget.325525840419
   PubMedGoogle Scholar
• Fernandez S, Risolino M, Mandia N, et al. miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer. Oncogene. 2015;34(25):3240–3250. doi:10.1038/onc.2014.26725151966
   PubMed Web of Science ®Google Scholar
• Yang RY, Hsu DK, Liu FT. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci U S A. 1996;93(13):6737–6742. doi:10.1073/pnas.93.13.67378692888
   PubMed Web of Science ®Google Scholar
• Sun W, Hu S, Zu Y, Deng Y. KLF3 is a crucial regulator of metastasis by controlling STAT3 expression in lung cancer. Mol Carcinog. 2019;58(11):1933–1945. doi:10.1002/mc.2307231486564
   PubMed Web of Science ®Google Scholar